You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
邁克生物(300463.SZ):目前暫無投資AI診斷或信息化產品公司的具體計劃
格隆匯 02-17 09:06

格隆匯2月17日丨邁克生物(300463.SZ)在投資者互動平臺表示,公司目前暫無投資AI診斷或信息化產品公司的具體計劃。關於DeepSeek等AI技術平臺的問題,我們認爲關鍵在於技術與實際業務場景的深度融合,雖然許多企業宣稱接入AI技術,但真正實現高效結合並解決實際問題,仍需考慮以下幾個方面: 1、技術匹配度:AI技術需要與企業的核心業務場景高度匹配。例如,在醫療領域,AI技術需具備高精度、高可靠性的數據處理能力,纔能有效提升診斷效率和準確性。2. 數據基礎:AI技術的應用離不開高質量的數據支持。企業需要具備完善的數據採集、存儲和管理能力,才能充分發揮AI技術的潛力。3. 研發與整合能力:接入AI技術並非簡單的技術引入,而是需要企業具備強大的研發能力和技術整合能力,將AI技術與現有產品、流程無縫結合。4. 實際應用效果:AI技術的價值最終體現在實際應用效果上。企業需要通過持續的優化和迭代,確保AI技術能夠真正解決用戶痛點,提升產品競爭力。 目前,邁克生物在智慧化實驗室建設中,已通過自主研發實現了從樣本採集到檢測結果的全流程智能化管理,並在AI輔助檢測等領域取得了一定成果。我們始終堅持以用戶需求爲導向,推動技術與業務的深度融合。未來,我們將持續關注行業前沿技術,結合自身優勢,探索更多創新應用場景。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account